United States Erdosteine Market Report 2018

January 2018 | 96 pages | ID: UC274D672E3EN
QYResearch

Abstracts

In this report, the United States Erdosteine market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Erdosteine in these regions, from 2013 to 2025 (forecast).

United States Erdosteine market competition by top manufacturers/players, with Erdosteine sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Edmond Pharma
• Alitair Pharmaceuticals
• Zhejiang Kangle Pharmaceutical
• Wuhan Yuancheng Pharmaceutical
• Shanghai Pukang Pharmaceuticals

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Tablets
• Capsules

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Bronchitis
• Nasopharyngitis
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Erdosteine Market Report 2018

1 ERDOSTEINE OVERVIEW

1.1 Product Overview and Scope of Erdosteine
1.2 Classification of Erdosteine by Product Category
  1.2.1 United States Erdosteine Market Size (Sales Volume) Comparison by Type (2013-2025)
  1.2.2 United States Erdosteine Market Size (Sales Volume) Market Share by Type (Product Category) in 2017
  1.2.3 Tablets
  1.2.4 Capsules
1.3 United States Erdosteine Market by Application/End Users
  1.3.1 United States Erdosteine Market Size (Consumption) and Market Share Comparison by Application (2013-2025)
  1.3.2 Bronchitis
  1.3.3 Nasopharyngitis
  1.3.4 Others
1.4 United States Erdosteine Market by Region
  1.4.1 United States Erdosteine Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 The West Erdosteine Status and Prospect (2013-2025)
  1.4.3 Southwest Erdosteine Status and Prospect (2013-2025)
  1.4.4 The Middle Atlantic Erdosteine Status and Prospect (2013-2025)
  1.4.5 New England Erdosteine Status and Prospect (2013-2025)
  1.4.6 The South Erdosteine Status and Prospect (2013-2025)
  1.4.7 The Midwest Erdosteine Status and Prospect (2013-2025)
1.5 United States Market Size (Value and Volume) of Erdosteine (2013-2025)
  1.5.1 United States Erdosteine Sales and Growth Rate (2013-2025)
  1.5.2 United States Erdosteine Revenue and Growth Rate (2013-2025)

2 UNITED STATES ERDOSTEINE MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Erdosteine Sales and Market Share of Key Players/Suppliers (2013-2018)
2.2 United States Erdosteine Revenue and Share by Players/Suppliers (2013-2018)
2.3 United States Erdosteine Average Price by Players/Suppliers (2013-2018)
2.4 United States Erdosteine Market Competitive Situation and Trends
  2.4.1 United States Erdosteine Market Concentration Rate
  2.4.2 United States Erdosteine Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Erdosteine Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES ERDOSTEINE SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2013-2018)

3.1 United States Erdosteine Sales and Market Share by Region (2013-2018)
3.2 United States Erdosteine Revenue and Market Share by Region (2013-2018)
3.3 United States Erdosteine Price by Region (2013-2018)

4 UNITED STATES ERDOSTEINE SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2013-2018)

4.1 United States Erdosteine Sales and Market Share by Type (Product Category) (2013-2018)
4.2 United States Erdosteine Revenue and Market Share by Type (2013-2018)
4.3 United States Erdosteine Price by Type (2013-2018)
4.4 United States Erdosteine Sales Growth Rate by Type (2013-2018)

5 UNITED STATES ERDOSTEINE SALES (VOLUME) BY APPLICATION (2013-2018)

5.1 United States Erdosteine Sales and Market Share by Application (2013-2018)
5.2 United States Erdosteine Sales Growth Rate by Application (2013-2018)
5.3 Market Drivers and Opportunities

6 UNITED STATES ERDOSTEINE PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Edmond Pharma
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Erdosteine Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Edmond Pharma Erdosteine Sales, Revenue, Price and Gross Margin (2013-2018)
  6.1.4 Main Business/Business Overview
6.2 Alitair Pharmaceuticals
  6.2.2 Erdosteine Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Alitair Pharmaceuticals Erdosteine Sales, Revenue, Price and Gross Margin (2013-2018)
  6.2.4 Main Business/Business Overview
6.3 Zhejiang Kangle Pharmaceutical
  6.3.2 Erdosteine Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Zhejiang Kangle Pharmaceutical Erdosteine Sales, Revenue, Price and Gross Margin (2013-2018)
  6.3.4 Main Business/Business Overview
6.4 Wuhan Yuancheng Pharmaceutical
  6.4.2 Erdosteine Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Wuhan Yuancheng Pharmaceutical Erdosteine Sales, Revenue, Price and Gross Margin (2013-2018)
  6.4.4 Main Business/Business Overview
6.5 Shanghai Pukang Pharmaceuticals
  6.5.2 Erdosteine Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Shanghai Pukang Pharmaceuticals Erdosteine Sales, Revenue, Price and Gross Margin (2013-2018)
  6.5.4 Main Business/Business Overview

7 ERDOSTEINE MANUFACTURING COST ANALYSIS

7.1 Erdosteine Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Erdosteine

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Erdosteine Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Erdosteine Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES ERDOSTEINE MARKET SIZE (VALUE AND VOLUME) FORECAST (2018-2025)

11.1 United States Erdosteine Sales Volume, Revenue Forecast (2018-2025)
11.2 United States Erdosteine Sales Volume Forecast by Type (2018-2025)
11.3 United States Erdosteine Sales Volume Forecast by Application (2018-2025)
11.4 United States Erdosteine Sales Volume Forecast by Region (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Erdosteine
Figure United States Erdosteine Market Size (K Doses) by Type (2013-2025)
Figure United States Erdosteine Sales Volume Market Share by Type (Product Category) in 2017
Figure Tablets Product Picture
Figure Capsules Product Picture
Figure United States Erdosteine Market Size (K Doses) by Application (2013-2025)
Figure United States Sales Market Share of Erdosteine by Application in 2017
Figure Bronchitis Examples
Table Key Downstream Customer in Bronchitis
Figure Nasopharyngitis Examples
Table Key Downstream Customer in Nasopharyngitis
Figure Others Examples
Table Key Downstream Customer in Others
Figure United States Erdosteine Market Size (Million USD) by Region (2013-2025)
Figure The West Erdosteine Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest Erdosteine Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Middle Atlantic Erdosteine Revenue (Million USD) and Growth Rate (2013-2025)
Figure New England Erdosteine Revenue (Million USD) and Growth Rate (2013-2025)
Figure The South of US Erdosteine Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Midwest Erdosteine Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Erdosteine Sales (K Doses) and Growth Rate (2013-2025)
Figure United States Erdosteine Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Erdosteine Market Major Players Product Sales Volume (K Doses) (2013-2018)
Table United States Erdosteine Sales (K Doses) of Key Players/Suppliers (2013-2018)
Table United States Erdosteine Sales Share by Players/Suppliers (2013-2018)
Figure 2017 United States Erdosteine Sales Share by Players/Suppliers
Figure 2017 United States Erdosteine Sales Share by Players/Suppliers
Figure United States Erdosteine Market Major Players Product Revenue (Million USD) (2013-2018)
Table United States Erdosteine Revenue (Million USD) by Players/Suppliers (2013-2018)
Table United States Erdosteine Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 United States Erdosteine Revenue Share by Players/Suppliers
Figure 2017 United States Erdosteine Revenue Share by Players/Suppliers
Table United States Market Erdosteine Average Price (USD/Dose) of Key Players/Suppliers (2013-2018)
Figure United States Market Erdosteine Average Price (USD/Dose) of Key Players/Suppliers in 2017
Figure United States Erdosteine Market Share of Top 3 Players/Suppliers
Figure United States Erdosteine Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Erdosteine Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Erdosteine Product Category
Table United States Erdosteine Sales (K Doses) by Region (2013-2018)
Table United States Erdosteine Sales Share by Region (2013-2018)
Figure United States Erdosteine Sales Share by Region (2013-2018)
Figure United States Erdosteine Sales Market Share by Region in 2017
Table United States Erdosteine Revenue (Million USD) and Market Share by Region (2013-2018)
Table United States Erdosteine Revenue Share by Region (2013-2018)
Figure United States Erdosteine Revenue Market Share by Region (2013-2018)
Figure United States Erdosteine Revenue Market Share by Region in 2017
Table United States Erdosteine Price (USD/Dose) by Region (2013-2018)
Table United States Erdosteine Sales (K Doses) by Type (2013-2018)
Table United States Erdosteine Sales Share by Type (2013-2018)
Figure United States Erdosteine Sales Share by Type (2013-2018)
Figure United States Erdosteine Sales Market Share by Type in 2017
Table United States Erdosteine Revenue (Million USD) and Market Share by Type (2013-2018)
Table United States Erdosteine Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Erdosteine by Type (2013-2018)
Figure Revenue Market Share of Erdosteine by Type in 2017
Table United States Erdosteine Price (USD/Dose) by Types (2013-2018)
Figure United States Erdosteine Sales Growth Rate by Type (2013-2018)
Table United States Erdosteine Sales (K Doses) by Application (2013-2018)
Table United States Erdosteine Sales Market Share by Application (2013-2018)
Figure United States Erdosteine Sales Market Share by Application (2013-2018)
Figure United States Erdosteine Sales Market Share by Application in 2017
Table United States Erdosteine Sales Growth Rate by Application (2013-2018)
Figure United States Erdosteine Sales Growth Rate by Application (2013-2018)
Table Edmond Pharma Basic Information List
Table Edmond Pharma Erdosteine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Edmond Pharma Erdosteine Sales Growth Rate (2013-2018)
Figure Edmond Pharma Erdosteine Sales Market Share in United States (2013-2018)
Figure Edmond Pharma Erdosteine Revenue Market Share in United States (2013-2018)
Table Alitair Pharmaceuticals Basic Information List
Table Alitair Pharmaceuticals Erdosteine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Alitair Pharmaceuticals Erdosteine Sales Growth Rate (2013-2018)
Figure Alitair Pharmaceuticals Erdosteine Sales Market Share in United States (2013-2018)
Figure Alitair Pharmaceuticals Erdosteine Revenue Market Share in United States (2013-2018)
Table Zhejiang Kangle Pharmaceutical Basic Information List
Table Zhejiang Kangle Pharmaceutical Erdosteine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Zhejiang Kangle Pharmaceutical Erdosteine Sales Growth Rate (2013-2018)
Figure Zhejiang Kangle Pharmaceutical Erdosteine Sales Market Share in United States (2013-2018)
Figure Zhejiang Kangle Pharmaceutical Erdosteine Revenue Market Share in United States (2013-2018)
Table Wuhan Yuancheng Pharmaceutical Basic Information List
Table Wuhan Yuancheng Pharmaceutical Erdosteine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Wuhan Yuancheng Pharmaceutical Erdosteine Sales Growth Rate (2013-2018)
Figure Wuhan Yuancheng Pharmaceutical Erdosteine Sales Market Share in United States (2013-2018)
Figure Wuhan Yuancheng Pharmaceutical Erdosteine Revenue Market Share in United States (2013-2018)
Table Shanghai Pukang Pharmaceuticals Basic Information List
Table Shanghai Pukang Pharmaceuticals Erdosteine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Shanghai Pukang Pharmaceuticals Erdosteine Sales Growth Rate (2013-2018)
Figure Shanghai Pukang Pharmaceuticals Erdosteine Sales Market Share in United States (2013-2018)
Figure Shanghai Pukang Pharmaceuticals Erdosteine Revenue Market Share in United States (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Erdosteine
Figure Manufacturing Process Analysis of Erdosteine
Figure Erdosteine Industrial Chain Analysis
Table Raw Materials Sources of Erdosteine Major Players/Suppliers in 2017
Table Major Buyers of Erdosteine
Table Distributors/Traders List
Figure United States Erdosteine Sales Volume (K Doses) and Growth Rate Forecast (2018-2025)
Figure United States Erdosteine Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure United States Erdosteine Price (USD/Dose) Trend Forecast (2018-2025)
Table United States Erdosteine Sales Volume (K Doses) Forecast by Type (2018-2025)
Figure United States Erdosteine Sales Volume (K Doses) Forecast by Type (2018-2025)
Figure United States Erdosteine Sales Volume (K Doses) Forecast by Type in 2025
Table United States Erdosteine Sales Volume (K Doses) Forecast by Application (2018-2025)
Figure United States Erdosteine Sales Volume (K Doses) Forecast by Application (2018-2025)
Figure United States Erdosteine Sales Volume (K Doses) Forecast by Application in 2025
Table United States Erdosteine Sales Volume (K Doses) Forecast by Region (2018-2025)
Table United States Erdosteine Sales Volume Share Forecast by Region (2018-2025)
Figure United States Erdosteine Sales Volume Share Forecast by Region (2018-2025)
Figure United States Erdosteine Sales Volume Share Forecast by Region in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources